tiprankstipranks
pc:boost

BOOST Pharma

A clinical-stage biopharmaceutical company advancing BT-101, a novel mesenchymal stem cell therapy for infants born with osteogenesis imperfecta, a condition characterized by fragile bones, frequent fractures, and bone deformity.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$49M
Total Amount Raised$49M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$34M
Latest Funding Amount$34M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 03, 2025
Investment
$34.00M
Oct 28, 2025
Convertible Notes
$15.00M

Investors

Investor Name
Funding Round
Convertible Notes
Convertible Notes
Investment

Related News and Analysis